GHS-R1a agonists show potential as anti-aging interventions by simultaneously restoring GH/IGF-1 axis, improving body composition, enhancing cardiovascular function, boosting immunity, and supporting cognition in aging.
Key findingGhrelin receptor agonists demonstrate multi-system anti-aging potential: restoring GH/IGF-1 axis, improving body composition (lean mass/fat ratio), en
What the researchers found
Ghrelin receptor agonists demonstrate multi-system anti-aging potential: restoring GH/IGF-1 axis, improving body composition (lean mass/fat ratio), enhancing cardiac function, boosting immune competence, and supporting cognitive function in aging models — comprehensive geroscience intervention.
Why it matters
Relevant for ghrp, mk-677, anti-aging, hormone-optimization.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
Annals of the New York Academy of Sciences, 1119, 147-64
Citation
Smith, Roy G; Sun, Yuxiang; Jiang, Hong; Albarran-Zeckler, Rosie; Timchenko, Nikolai. (2007). Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.. Annals of the New York Academy of Sciences, 1119, 147-64.